Note: Ingredients listed on restricted chemical lists
EC/CAS
9005-67-8
Name of the chemical
polyethyleneglycol sorbitan monostearate
Concentration
(%
General Information
Revision date
2007-07-30
Product name
(=Polyoxyethylene Sorbitan Monostearate)
Product Synonyms
Polyoxyethylene-40-sorbitan Monostearate
Chemical name
(=Polyoxyethylene Sorbitan Monostearate)
CAS No.
9005-67-8
supplier name
TCI America
Emergency telephone
(800) 424-9300, (703) 527-3887
Icons in SDS
Company Information
company name
TCI America
Section 2
Potential Acute Health Effects
No specific information is available in our data base regarding the toxic effects of this material for humans. However, exposure to any chemical should be kept to a minimum. Skin and eye contact may result in irritation. May be harmful if inhaled or ingested. Always follow safe industrial hygiene practices and wear proper protective equipment when handling this compound. Follow safe industrial hygiene practices and always wear proper protective equipment when handling this compound.
Potential chronic health
CARCINOGENIC EFFECTS Not available. MUTAGENIC EFFECTS Not available.
Teratogenic Effects
Tumorigenic Effects: Rat TDLo (subcutaneous) 2100 mg/kg/7 weeks intermittent. Toxic Effects: Tumorigenic - Equivocal tumorigenic agent by RTECS criteria. Tumorigenic - Tumors at site of application. Mouse (dermal) 168 gm/kg/35 weeks intermittent. Toxic Effects: Tumorigenic - Equivocal tumorigenic agent by RTECS criteria. Skin and Appendages - Tumors. Tumorigenic - Tumors at site of application. DEVELOPMENTAL TOXICITY: Reproductive Effects: Rat TDLo (oral) 635 gm/kg, female multigenerations. Toxic Effects: Effects on Newborn - Viability index. Effects on Newborn - Weaning or lactation index. Rat TDLo (oral) 1270 gm/kg, female 84 days prior to mating - 21 days after birth. Toxic Effects: Effects on Newborn - Viability index. Mouse TDLo (oral) 41600 mg/kg, female 7-14 days of pregnancy. Toxic Effects: Effects on Newborn - Growth statistics. Repeated or prolonged exposure to this compound is not known to aggravate existing medical conditions.
